Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-17

Clinical Trial Update: Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations [Phase 1]

View source ↗

Summary

Duke University is conducting a Phase 1 clinical trial to investigate senolytic properties in combination with pulmonary rehabilitation and Metformin for COPD e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: Duke University | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 1 | Status: NOT_YET_RECRUITING